PathAI Expands AISight Dx with v2.17 Release: Presentation Queues for Tumor Boards, Consult ...

PathAI, the global leader in AI-powered pathology, today announced AISight® Dx1 v2.17, introducing three new capabilities to ...

Tempus Announces Six Abstracts Accepted for Presentation at the European Society for ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...